TY - JOUR
T1 - The mechanism of Ara-C-induced apoptosis of differentiating cerebellar granule neurons
AU - Courtney, M J
AU - Coffey, E T
PY - 1999/3
Y1 - 1999/3
N2 - Neurotoxicity is one of the side-effects of the therapeutically useful antitumour agent, Ara-C (or 1-beta-d-arabinofuranosyl-cytosine, cytarabine). This agent is also reported to induce cell death of cultured neurons. In this study, we show that Ara-C-induced death of differentiating rat cerebellar granule neurons is prevented by cycloheximide at concentrations corresponding to its action in preventing protein synthesis. The death is accompanied by cleavage of the caspase substrate poly ADP ribose polymerase (PARP) and c-Abl-dependent activation of the stress-activated protein kinases c-Jun N-terminal kinase and p38. However, c-Jun levels do not rise and the activation of the stress-activated protein kinases is not required for this form of neuronal death. Cyclin-dependent kinase (cdk) activity and inappropriate cell-cycle re-entry have been implicated in some forms of death in differentiated neurons. Here we show that Ara-C-induced death of cerebellar granule neurons is prevented by an inhibitor of cdk4, whereas inhibition of cdk1, -2 and -5 mimics the death, and non-cdk4/6 cdks are inhibited by Ara-C treatment. Cdk1 and -2 are dramatically down-regulated during neuronal differentiation, and neither Ara-C nor inhibition of these cdks induces death in mature neurons. This mechanism could also play a significant role in the neurotoxicity associated with the therapeutic use of Ara-C, as cdk levels can be upregulated in stressed neurons of adult brain. We propose that the balance between cdk4/6 and cdk1/2/5 activity may determine the survival of early differentiating neurons, and that DNA-damaging agents may induce neuronal death by inhibiting cdk1/2/5 under conditions which require these activities for survival.
AB - Neurotoxicity is one of the side-effects of the therapeutically useful antitumour agent, Ara-C (or 1-beta-d-arabinofuranosyl-cytosine, cytarabine). This agent is also reported to induce cell death of cultured neurons. In this study, we show that Ara-C-induced death of differentiating rat cerebellar granule neurons is prevented by cycloheximide at concentrations corresponding to its action in preventing protein synthesis. The death is accompanied by cleavage of the caspase substrate poly ADP ribose polymerase (PARP) and c-Abl-dependent activation of the stress-activated protein kinases c-Jun N-terminal kinase and p38. However, c-Jun levels do not rise and the activation of the stress-activated protein kinases is not required for this form of neuronal death. Cyclin-dependent kinase (cdk) activity and inappropriate cell-cycle re-entry have been implicated in some forms of death in differentiated neurons. Here we show that Ara-C-induced death of cerebellar granule neurons is prevented by an inhibitor of cdk4, whereas inhibition of cdk1, -2 and -5 mimics the death, and non-cdk4/6 cdks are inhibited by Ara-C treatment. Cdk1 and -2 are dramatically down-regulated during neuronal differentiation, and neither Ara-C nor inhibition of these cdks induces death in mature neurons. This mechanism could also play a significant role in the neurotoxicity associated with the therapeutic use of Ara-C, as cdk levels can be upregulated in stressed neurons of adult brain. We propose that the balance between cdk4/6 and cdk1/2/5 activity may determine the survival of early differentiating neurons, and that DNA-damaging agents may induce neuronal death by inhibiting cdk1/2/5 under conditions which require these activities for survival.
KW - Androstadienes/pharmacology
KW - Animals
KW - Antimetabolites, Antineoplastic/pharmacology
KW - Apoptosis/drug effects
KW - Benzamides
KW - CDC2 Protein Kinase/analysis
KW - CDC2-CDC28 Kinases
KW - Cell Differentiation/physiology
KW - Cell Survival/physiology
KW - Cerebellum/cytology
KW - Cyclin-Dependent Kinase 2
KW - Cyclin-Dependent Kinase 4
KW - Cyclin-Dependent Kinase 5
KW - Cyclin-Dependent Kinases/analysis
KW - Cytarabine/pharmacology
KW - Enzyme Inhibitors/pharmacology
KW - Flavonoids/pharmacology
KW - Imatinib Mesylate
KW - Imidazoles/pharmacology
KW - Mitogen-Activated Protein Kinase 12
KW - Mitogen-Activated Protein Kinases
KW - Neurons/chemistry
KW - Piperazines/pharmacology
KW - Piperidines/pharmacology
KW - Poly (ADP-Ribose) Polymerase-1
KW - Poly(ADP-ribose) Polymerases
KW - Protein Kinases/metabolism
KW - Protein Serine-Threonine Kinases/analysis
KW - Proteins/metabolism
KW - Proto-Oncogene Proteins
KW - Purines/pharmacology
KW - Pyridines/pharmacology
KW - Pyrimidines/pharmacology
KW - Rats
KW - Roscovitine
KW - Signal Transduction/physiology
KW - Stress, Physiological/enzymology
KW - Wortmannin
U2 - 10.1046/j.1460-9568.1999.00520.x
DO - 10.1046/j.1460-9568.1999.00520.x
M3 - Article
C2 - 10103100
SN - 0953-816X
VL - 11
SP - 1073
EP - 1084
JO - European Journal of Neuroscience
JF - European Journal of Neuroscience
IS - 3
ER -